RSI at 14 on the Contact Lens Maker, and a Repeat Director Steps In

ISB Research · Interesting · sent to Ultimate members September 15, 2026

The RSI on Cooper Companies just printed 14. That's about as washed out as the tape gets, and Walter Rosebrough, a director at the company behind CooperVision contact lenses and CooperSurgical fertility products, put $541,640 into it right at $54.16. He's not the only one buying either. Two insiders have stepped in over the past month, and Rosebrough has bought this name before. History says the follow-through is decent short term, with insider buys on Cooper working about 70% of the time at 30 days, though the 90-day picture flattens out, so this is a bounce trade more than a hold. Healthcare has held up over three months even with the recent softness, and a director loading up at the bottom of an RSI-14 flush deserves your attention.

Ultimate members received this analysis in real time.